Changes of CK-MB in OHS by Using of Different Cardioplegia

개심술시 CK-MB치 변화 [심근보호]

  • Published : 1993.12.01

Abstract

Possible enhancement of myocardial protection with oxygenated crystalloid cardioplegia and blood cardioplegia were evaluated in a cardiac enzyme study. The bicarbonate-containing solution equilibrated with 100% oxygen becomes highly alkaline as carbon dioxide is released. 95% oxygen and 5% carbon dioxide was added to the crystalloid cardioplegic solution[St. Thomas` Hospital No. 2 Solution] for prevention of severe alkalinity of oxygenated crystalloid cardioplegia. Heart was arrested and reinfused every 20 minutes throughtout the ischemic period with crystalloid cardioplegia or oxygenated crystalloid cardioplegia or blood cardioplegia. Group I was a patient with crystalloid cardioplegia in 11 patients. Group II was a patient with oxygenated crystalloid cardioplegia in 9 patients. Group III was a patient with blood cardioplegia in 15 patients. The value of CK-MB was evaluated from the patient`s serum at 6 hours, 24 hours, and 48 hours postoperatively.In Group I and II, there was no significant change of CK-MB. In Group I and 11I, the value of CK-MB at postoperative 6 hours was 114 + 83 ng/ml and 56 + 22 ng/ml [P [0.05]. In conclusion, blood cardioplegia was superior to crystalloid cardioplegia.

Keywords

References

  1. J. Thorac Cardiovasc Surg v.85 Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution Bodenhamer,R.M.;DeBoer,L.W.V.;Geffin,G.A.(et al.)
  2. Ann. Thorac. Surg. v.33 Clinical evaluation of the relative effectiveness of multidose crystalloid and cold blood potassium cardioplegia in coronary artery bypass graft surgery Roberts,A.J.;Moran,J.M.;Sanders,J.H.(et al.)
  3. Ann. Thorac. Surg. v.33 Myocardial protection with cold blood potassium cardioplegia during prolonged aortic cross-clamping Catinella,F.P.;Cunningham,J.N.;Adams,P.X.;Snively,S.L.;Gross,R.L.;Spencer,F.C.
  4. J. Thorac. Cardiovasc. Surg. v.76 Advantages of the blood cardioplegia over continuous coronary perfusion and intermittent ischemia Follette,D.M.;Mulder,D.G.;Maloney,J.V.;Buckberg,G.D.
  5. J. Thorac. Cardiovasc. Surg. v.73 Studies of the effect of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart Buckberg,G.D.;Brazler,J.R.;Goldstein,S.M.;McConnell,D.H.;Cooper,N.
  6. Lancet v.2 Elective cardiac arrest Melrose,D.G.;Dreyer,B.;Bentall,H.H.;Baker,H.H.;Baker,J.B.E.
  7. J. Thorac. Cardiovasc. Surg. v.74 Prolonged safe aortic clamping by combining membrane stabilization, multidose cardioplegia and approprite PH reperfusion Follette,D.M.;Fey,K.;Mulder,D.G.;Maloney,J.V.Jr;Buckberg,G.D.
  8. N. Engl. J. Med. v.312 Oxygen-derived free radicals in postischemic tissue injury McCord,J.M.
  9. Circulation v.75 Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinat human superoxide dismutase administered at the time of reflow Ambrosio,G.;Weisfeldt,M.L.;Jacobus,W.E.;Flaherty,J.T.
  10. J. Thorac. Cardiovasc. Surg. v.86 Inhibition of surgically induced ischemial reperfusion injury by oxygen free radical scavengers Steward,J.R.;Blackwell,W.H.;Crute,S.L.;Loughlin,V.;Greenfield,L.J.;Hess,M.L.
  11. Surg. Forum v.36 Enhancement of myocardial salvage by intravenous Co-enzyme Q10 before surgical reperfusion with substrate enriched blood cardioplegia Okamoto,F.;Allen,B.S.;Buckberg,G.D.(et al.)
  12. J. Appl. Physiol. v.12 Oxyhemoglobin dissociation curve correction for temperature and pH variation on human blood Severinghaus,J.W.
  13. Ann. Thorac. Surg. v.29 Clinical Experince with Cold Blood as the Vehicle for Hypothermic Potassium Cardioplegia Barner,H.B.;Kaiser,G.C.;Codd,J.E.(et al.)
  14. J. Thorac. Cardiovasc. Surg. v.87 The potential hazard of particulate contamination of cardioplegic solutions Robinson,L.A.;Braimbride,M.V.;Hearse,D.J.
  15. J. Thorac. Cardiovasc. Surg. v.79 Comparision of single-dose and multi-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusion Takamoto,S.;Levine,F.H.;LaRaia.P.J.(et al.)
  16. J. Thorac. cardiovasc. Surg. v.88 Safety of prolonged aortic clamping with blood cardioplegia. I. Glutamate enrichment in normal hearts Robertson,J.M.;Vinten-Johansen,J.;Buckberg,G.D.(et al.)
  17. J. Thorac. Cardiovasc. Surg. v.86 Comparison of distribution beyond coronary stenoses of blood and asanguineous cardioplegic solution Robertson,J.M.;Buckberg,G.D.;Vinten-Johansen,J.;Leaf,J.D.
  18. Harrison's principles of Internal Medicine(10th ed.) Lactic Acidosis Foster,D.W.;Petersdorf,R.G.;Adams,R.D.;Braunwald,E.(et al.)
  19. Harrison's Principles of Internal Medicine(10th ed.) Acute Myocardial Infarction Braunwald,E.;Alpert,J.S.;Petersdorf,R.G.;Adams,R.D.;Braunwald,E.(et al.)
  20. Clinical diagnosis and management(18th ed.) Clinical Enzymology Pincus,M.R.;Zimmerman,H.J.;Henry,J.B.
  21. J. Thorac. Cardiovasc. Surg. v.102 Effect of oxygenation and consequent of pH changes on the efficacy of St. Thomas Hospital cardioplegic solution Von Oppell,U.O.;King,L.M.;Du Toit,E.F.(et al.)
  22. J. Thorac. cardiovasc. Surg. v.94 Oxygenation of cardioplegic solutions. Potential for the calcium paradox Hendren,W.G.;Geffin,G.A.;Love,T.R.(et al.)
  23. J. Thorac. Cardiovasc. Surg. v.102 St. Thomas' Hospital cardioplegic solution, beneficial effect of glucose and multidose reinfusions of cardioplegic solution Von Oppell,U.O.;Du Toit,E.F.;King,L.M.(et al.)